Trial Profile
Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jun 2008
Price :
$35
*
At a glance
- Drugs Niacin/simvastatin (Primary) ; Simvastatin
- Indications Hyperlipoproteinaemia; Lipid metabolism disorders
- Focus Registrational; Therapeutic Use
- Acronyms SEACOAST; SEACOAST-I; SEACOAST-II
- 15 May 2008 Results of SEACOAST I published in American Journal of Cardiology.
- 08 Aug 2006 Status change
- 30 Aug 2005 New trial record.